Dose up on health-care stocks
By on Feb 1, 2010 in Finances
For health-care investors, 2009 was a year to forget. While the rest of the market surged, shares of most drugmakers, biotechs, and managed-care companies lingered in the sick ward, weakened by investors’ preference for riskier assets and, more fundamental, uncertainty by health-care reform.
Original post by Technology news - Business 2.0 Magazine
You must be logged in to post a comment.